[1] |
CAON I, BARTOLINI B, PARNIGONI A, et al. Revisiting the hallmarks of cancer:the role of hyaluronan[J]. Semin Cancer Biol, 2020, 62:9-19.
DOI
URL
|
[2] |
LI P, XIANG T, LI H, et al. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer[J]. Int J Clin Exp Pathol, 2015, 8(10):12101-12114.
|
[3] |
LIAGHATI P, MOMENI P, ESFANDI F, et al. Expression analysis of CD24 and CD44 transcripts in Iranian breast cancer patients[J]. Breast Dis, 2020, 39(3-4):143-148.
DOI
PMID
|
[4] |
XU H, WU K, TIAN Y, et al. CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer[J]. Int J Oncol, 2016, 49(4):1343-1350.
DOI
PMID
|
[5] |
AUVINEN P, RILLA K, TUMELIUS R, et al. Hyaluronan synthases(HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival[J]. Breast Cancer Res Treat, 2014, 143(2):277-286.
DOI
URL
|
[6] |
UDABAGE L, BROWNLEE G R, NILSSON S K, et al. The over-expression of HAS2,Hyal-2 and CD44 is implicated in the invasiveness of breast cancer[J]. Exp Cell Res, 2005, 310(1):205-217.
DOI
URL
|
[7] |
KOLLIOPOULOS C, LIN C Y, HELDIN C H, et al. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer[J]. Matrix Biol, 2019, 80:29-45.
DOI
PMID
|
[8] |
YANG C, CAO M, LIU Y, et al. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas[J]. Oncogene, 2019, 38(46):7113-7132.
DOI
PMID
|
[9] |
盛雨梦, 许静, 刘鷖雯, 等. 血清HA、HAS2在骨肿瘤辅助诊断及疗效监测中的价值[J]. 检验医学, 2021, 36(2):162-166.
|
[10] |
DASARI S, RAJENDRA W, VALLURU L. Evaluation of soluble CD44 protein marker to distinguish the premalignant and malignant carcinoma cases in cervical cancer patients[J]. Med Oncol, 2014, 31(9):139.
DOI
PMID
|
[11] |
SAWANT S, AHIRE C, DONGRE H, et al. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma[J]. J Oral Pathol Med, 2018, 47(7):665-673.
DOI
PMID
|
[12] |
NOTTEGAR A, VERONESE N, SENTHIL M, et al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients:a systematic review and an exploratory meta-analysis[J]. Eur J Surg Oncol, 2016, 42(7):919-925.
DOI
URL
|
[13] |
MERIC-BERNSTAM F, JOHNSON A M, DUMBRAVA E E I, et al. Advances in HER2-targeted therapy:novel agents and opportunities beyond breast and gastric cancer[J]. Clin Cancer Res, 2019, 25(7):2033-2041.
DOI
URL
|